First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and PD data anticipated in Q1 2026 Advances ongoing ...

It is game time for SA’s Class of 2025 as matric exams get under way, starting with CAT and foreign languages before all ...

A degree in computer science used to promise a cozy career in tech. Now, students’ ambitions are shaped by AI, in fields that ...

EMA committee recommends approval of Insmed’s Brinsupri to treat non-cystic fibrosis bronchiectasis: Bridgewater, New Jersey Monday, October 20, 2025, 15:00 Hrs [IST] Insmed Inc ...

Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from solid tumors, confirming proof-of-concept with Phase 2 topline results ...

A labour relations professor is criticizing the Alberta government's threat to legislate striking teachers back to work as ...